Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.

Clinical trial NCT01705002 · COMPLETED

Trial details

NCT number: NCT01705002
Sponsor: Lipomedix Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Metastatic Colorectal Cancer (mCRC)

Start date: 2012-10-01
Primary completion: 2017-11-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.